1 active not recruiting, 1 unknown. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Intensified Follow-up Schedule: new trials by email Literature Review of Intensified Follow-up Schedule trials Research Report on Intensified Follow-up Schedule
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial ctDNA-analysis, Intensified Follow-up Schedule - Colorectal Cancer, Colo-rectal Cancer | Not applicable | Active not recruiting | Claus Lindbjerg Andersen | 359 | 2020-01-01 | 2026-04-29 |
| IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer Capox (or FOLFOX) including flouropyrimidine and oxaliplatin combination chemotherapy, Intensified Follow-up Schedule - Colorectal Cancer, Circulating Tumor DNA | Phase 2 | Unknown | Karen-Lise Garm Spindler | 64 | 2018-10-01 | 2022-02-25 |
Colorectal Neoplasms (2) · Colonic Diseases (1) · Colonic Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Neoplasms (1) · Rectal Diseases (1) · Rectal Neoplasms (1)
Claus Lindbjerg Andersen (1) · Karen-Lise Garm Spindler (1)
Denmark (2)